|
Hematologic Malignancies Grand Rounds 2020 |
01/03/2020 - 9:15am to 10:15am EST |
|
SNP Microarray Reveals Predicted Outcomes of a Novel High Risk AML Subgroup with ERG Amplification |
01/10/2020 - 9:15am to 10:15am EST |
|
Beyond Cellular Therapies Treating Relapsed DLBCL |
01/17/2020 - 9:15am to 10:15am EST |
|
Soothing the Savage Beast Taming High-Risk Myeloid Neoplasm |
01/24/2020 - 9:15am to 10:15am EST |
|
From Protein Neddylation to Histone Modification New Targets for Drug Development in AML |
01/31/2020 - 9:15am to 10:15am EST |
|
Tumor Board Cases |
02/07/2020 - 9:15am to 10:15am EST |
|
Beyond Hematology Clinical Significance of IgM MGUS A case-based presentation |
02/14/2020 - 9:15am to 10:15am EST |
|
So what are my options, Doc? Assessing Frailty and Fitness in Hematologic Malignancies |
02/21/2020 - 9:15am to 10:15am EST |
|
Current Status of BCMA CAR T Therapy for Multiple Myeloma |
02/28/2020 - 9:15am to 10:15am EST |
|
CLL in 2020 ASH Updates and Future Directions |
03/06/2020 - 9:15am to 10:15am EST |
